Identified Compound definition

Identified Compound means any of the compounds specifically identified in Exhibit F hereto. TSRI represents and warrants that each Identified Compound was identified and synthesized by TSRI on or before the Effective Date in connection with the practice of the Invention, but TSRI disclaims any representation or warranty regarding the efficacy, reliability, merchantability, fitness for a particular purpose, reproducibility of data, non-infringement of third party rights or arising out of course of conduct or trade custom or usage with respect to any Identified Compound.
Sample 1Sample 2Sample 3
Identified Compound means:
Sample 1Sample 2Sample 3
Identified Compound means a compound, or group of related compounds, that has been Characterised by Cerylid as a result of the Screening Activities, and that, as of the Structural Disclosure Date, is not:
Sample 1Sample 2

Examples of Identified Compound in a sentence

  • A This flag indicates that a Tentatively Identified Compound is a suspected aldol- condensation product.

  • Arena acknowledges and agrees that Taisho shall have sole discretion to: (i) determine which CART Identified Compound to develop as a first Drug Product, Back-Up Compound or Subsequent Compound; and (ii) whether or not to continue development of any CART Identified Compound or Drug Product.

  • As long as Taisho is using Taisho Activated Receptor, Screening Assay, CART Identified Compound and/or Drug Candidate, then all such payments shall be made by Taisho to Arena, even if this Agreement is not in full force and effect at the time that such payment is due.

  • Tentatively Identified Compound information is not generally reported to NJDEP as part of the routine monitoring performed by drinking water systems.

  • In the response to comments, we discuss the specific laboratory steps that must be taken in order to determine if a Tentatively Identified Compound is present and then how to proceed in order to determine the identity of the Tentatively Identified Compound.

  • The GC/MS confirmation may be accomplished by one of three general means: • Examination of the semivolatile GC/MS library search results [i.e., Tentatively Identified Compound (TIC) data]; or • A second analysis of the semivolatile extract; or • Analysis of the Aroclor extract, following any solvent exchange and concentration steps that may be necessary.

  • TSRI represents and warrants that each Identified Compound was identified and synthesized by TSRI on or before the Effective Date in connection with the practice of the Invention, but TSRI disclaims any representation or warranty regarding the efficacy, reliability, merchantability, fitness for a particular purpose, reproducibility of data, non-infringement of third party rights or arising out of course of conduct or trade custom or usage with respect to any Identified Compound.

  • The amount of any milestone payment to TSRI with respect to a Milestone Product that is a Partner Product shall be creditable against any current or future Aggregate Technology Income obligations that are or may become payable to TSRI under Section 4.2 for the same Identified Compound.

  • The term “Partner Product” shall mean any product that contains an Identified Compound, but excluding any Company Product.

  • Taisho shall provide Notice to Arena of its decision to implement Taisho Development of a CART Identified Compound.


More Definitions of Identified Compound

Identified Compound means (a) opioid alkaloid morphine and/or a salt thereof ("Morphine"), (b) Fentanyl, (c) Midazolam, and (d) such other drug compound agreed to by the parties in accordance with Section 3.2 hereof.
Sample 1Sample 2

Related to Identified Compound

  • Licensed Compound means [***].

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Development Candidate means a Collaboration Compound designated by Biogen Idec as a Development Candidate in accordance with Section 2.6.

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Exempt compound means the same as defined in Rule 2.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Compounds means any or all of the following chemicals, as the context requires:

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Combination Product means any product that comprises a Licensed Compound or Licensed Product sold in conjunction with another active component so as to be a combination product (whether packaged together or in the same therapeutic formulation).

  • Biosimilar Product means, with respect to a Licensed Product in any country, any biosimilar product sold by a Third Party not authorized by or on behalf of Celgene, its Affiliates or Sublicensees, (a) that is a biosimilar biological product, as defined in 21 USC 379j-51 (or any successor or replacement thereof), a similar biological medicinal product, as defined in Annex I to Directive 2001/83/EC (or any successor or replacement thereof), or any similar biosimilar or generic product under the Laws of any country or jurisdiction, or (b) regarding which Regulatory Approval is obtained by referencing Regulatory Data of such Licensed Product.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Licensed Product means a product, method or service in the Licensed Field of Use, the making, having made, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent.

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.

  • Drug Substance means an active ingredient that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient.

  • Covered Product The consumer product that You purchased concurrently with and is covered by this Agreement.

  • Biological Material means any material containing genetic information and capable of reproducing itself or being reproduced in a biological system;